Select Medical Holdings Corporation Announces Stockholder Approval of Acquisition by Consortium Led by Robert A. Ortenzio, Martin F. Jackson, and WCAS

Select Medical Holdings (SEM) announced that its stockholders have approved the proposed acquisition by a consortium led by co-founder and executive Robert A. Ortenzio, CFO Martin F. Jackson, and private equity firm WCAS (Welsh, Carson, Anderson & Stowe). The vote clears the largest remaining hurdle for the go-private transaction, which takes the company off public markets with founding management rolling equity alongside a major healthcare-focused PE backer.

SEM is a $5.5B revenue business growing at roughly 5% year-over-year with a thin 3.9% net margin and $1.16 in diluted EPS. The lean margins mean the deal thesis likely centers on operational restructuring and debt-capacity improvements away from public scrutiny — a classic WCAS playbook in healthcare services.

With the stockholder vote done, the remaining risks are regulatory clearance (antitrust) and customary closing conditions. The trade now is a pure merger arbitrage setup: the spread between where SEM trades and the deal price reflects time value and residual deal-break risk. Given management is leading the buyer consortium, the probability of a walkaway or bid reduction is structurally lower than a third-party acquirer scenario.

The bear case is deal timeline slippage or a surprise regulatory challenge, which could widen the arb spread and pressure the stock. The bull case is a clean, fast close that delivers the full deal consideration, letting arb players capture the remaining spread. Watch for a Form 8-K or press release announcing a closing date, which would be the next material catalyst.